103 related articles for article (PubMed ID: 30676731)
1. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
[TBL] [Abstract][Full Text] [Related]
2. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds.
Duscher D; Trotsyuk AA; Maan ZN; Kwon SH; Rodrigues M; Engel K; Stern-Buchbinder ZA; Bonham CA; Barrera J; Whittam AJ; Hu MS; Inayathullah M; Rajadas J; Gurtner GC
J Control Release; 2019 Aug; 308():232-239. PubMed ID: 31299261
[TBL] [Abstract][Full Text] [Related]
3. A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine.
Michailidou G; Li Y; Zamboulis A; Karlioti G; Meimaroglou D; Pantopoulos K; Bikiaris DN
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255991
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of deferoxamine-based nanochelator in rats.
Jones G; Zeng L; Stiles WR; Park SH; Kang H; Choi HS; Kim J
Nanomedicine (Lond); 2022 Sep; 17(22):1649-1662. PubMed ID: 36547231
[TBL] [Abstract][Full Text] [Related]
5. Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO).
Lazaridou M; Christodoulou E; Nerantzaki M; Kostoglou M; Lambropoulou DA; Katsarou A; Pantopoulos K; Bikiaris DN
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32156022
[TBL] [Abstract][Full Text] [Related]
6. The iron chelator deferoxamine decreases myeloma cell survival.
Yang F; Wu Z; Dai D; Zhang L; Zhang X; Zhang X; Xu Y
J Int Med Res; 2021 Jan; 49(1):300060520987396. PubMed ID: 33478296
[TBL] [Abstract][Full Text] [Related]
7. Deferoxamine to Minimize Fibrosis During Radiation Therapy.
Tevlin R; Longaker MT; Wan DC
Adv Wound Care (New Rochelle); 2022 Oct; 11(10):548-559. PubMed ID: 34074152
[No Abstract] [Full Text] [Related]
8. Deferoxamine produces nitric oxide under ferricyanide oxidation, blood incubation, and UV-irradiation.
Mukosera GT; Liu T; Manaen M; Zhu L; Power G; Schroeder H; Blood AB
Free Radic Biol Med; 2020 Nov; 160():458-470. PubMed ID: 32828952
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Polymeric Micelles for Combining Chelation and Detection of Iron in Living Cells.
Liu Z; Purro M; Qiao J; Xiong MP
Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28661064
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.
Huang HC; Rizvi I; Liu J; Anbil S; Kalra A; Lee H; Baglo Y; Paz N; Hayden D; Pereira S; Pogue BW; Fitzgerald J; Hasan T
Cancer Res; 2018 Jan; 78(2):558-571. PubMed ID: 29187403
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Analysis of DFO-Resistant Huh7 Cells and Identification of Targets for Combination Therapy.
Fujisawa K; Matsumoto T; Yamamoto N; Yamasaki T; Takami T
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887398
[TBL] [Abstract][Full Text] [Related]
12. Chelation of Mitochondrial Iron as an Antiparasitic Strategy.
Arbon D; Mach J; Čadková A; Sipkova A; Stursa J; Klanicová K; Machado M; Ganter M; Levytska V; Sojka D; Truksa J; Werner L; Sutak R
ACS Infect Dis; 2024 Feb; 10(2):676-687. PubMed ID: 38287902
[TBL] [Abstract][Full Text] [Related]
13. Bile Acid-Targeted Hyaluronic Acid Nanoparticles for Enhanced Oral Absorption of Deferoxamine.
Agboluaje EO; Cui S; Grimsey NJ; Xiong MP
AAPS J; 2024 Apr; 26(3):46. PubMed ID: 38609650
[TBL] [Abstract][Full Text] [Related]
14. Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer.
Bayanbold K; Singhania M; Fath MA; Searby CC; Stolwijk JM; Henrich JB; Pulliam CF; Schoenfeld JD; Mapuskar KA; Sho S; Caster JM; Allen BG; Buettner GR; Spies M; Goswami PC; Petronek MS; Spitz DR
Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001858
[TBL] [Abstract][Full Text] [Related]
15. MALDI-mass spectrometry imaging as a new technique for detecting non-heme iron in peripheral tissues via caudal vein injection of deferoxamine.
Jin X; Shi X; Zhang T; Li X; Xie Y; Tian S; Han K
Anal Bioanal Chem; 2024 Apr; ():. PubMed ID: 38632130
[TBL] [Abstract][Full Text] [Related]
16. Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets.
Schneidewind T; Brause A; Pahl A; Burhop A; Mejuch T; Sievers S; Waldmann H; Ziegler S
Chembiochem; 2020 Nov; 21(22):3197-3207. PubMed ID: 32618075
[TBL] [Abstract][Full Text] [Related]
17. Cellular Iron Deficiency Disrupts Thyroid Hormone Regulated Gene Expression in Developing Hippocampal Neurons.
Monko TR; Tripp EH; Burr SE; Gunderson KN; Lanier LM; Georgieff MK; Bastian TW
bioRxiv; 2023 Jun; ():. PubMed ID: 37398002
[TBL] [Abstract][Full Text] [Related]
18. Combating iron overload: a case for deferoxamine-based nanochelators.
Jones G; Goswami SK; Kang H; Choi HS; Kim J
Nanomedicine (Lond); 2020 May; 15(13):1341-56. PubMed ID: 32429801
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Alginate-Deferoxamine Conjugates With Blood Components and Their Antioxidation in the Hemoglobin Oxidation Model.
Sun T; Guo X; Zhong R; Wang C; Liu H; Li H; Ma L; Guan J; You C; Tian M
Front Bioeng Biotechnol; 2020; 8():53. PubMed ID: 32117933
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
